Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

Study ID: NCT05069038
Start Date: 2022-03-02
End Date: 2031-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

46

Intervention / Treatment

Palbociclib 125mg

Sponsor

University of Nebraska

Source: clinicaltrials.gov

Share:
Add to list

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

Study ID: NCT05189314
Start Date: 2019-08-30
End Date: 2027-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Thyroidectomy

Radiofrequency Ablation

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Pioglitazone Therapy Targeting Fatigue in Breast Cancer

Study ID: NCT05013255
Start Date: 2021-12-23
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Pioglitazone 15mg

Pioglitazone 30 mg

Sponsor

West Virginia University

Source: clinicaltrials.gov

Share:
Add to list

AIMS Medical Outcomes Study

Study ID: NCT04512755
Start Date: 2020-07-01
End Date: 2030-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

Advanced Integrative Medical Science Institute

Source: clinicaltrials.gov

Share:
Add to list

CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

Study ID: NCT04322955
Start Date: 2020-06-22
End Date: 2028-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

Cabozantinib

Nivolumab

Cytoreductive nephrectomy

Sponsor

Mark

Source: clinicaltrials.gov

Share:
Add to list

Safety and Effectiveness of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Study ID: NCT06712355
Start Date: 2025-02-03
End Date: 2028-09
Study Type

Interventional

Study Phase

Phase3

No. of Participants

439

Intervention / Treatment

Benah

Atezolizumab

Etoposide

Carboplatin

Sponsor

BioNTech SE

Source: clinicaltrials.gov

Share:
Add to list

Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanced Cancers

Study ID: NCT06722014
Start Date: 2025-03-27
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

STAMP + CBT

Digital Cancer Pain Education Packet

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

Study ID: NCT06909214
Start Date: 2025-04-17
End Date: 2027-05
Study Type

Interventional

Study Phase

Phase4

No. of Participants

30

Intervention / Treatment

Efgartigimod PH20 SC

Sponsor

argenx

Source: clinicaltrials.gov

Share:
Add to list

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

Study ID: NCT06050850
Start Date: 2023-10-17
End Date: 2029-10-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

46

Intervention / Treatment

NOURISH-ALL

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Genetic Testing in Young Adults With Cancer Study

Study ID: NCT04533555
Start Date: 2020-12-01
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1238

Intervention / Treatment

Broad gene panel for young adult cancers

Standard

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list